(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Clinical trial NCT05186753 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05186753
Sponsor: Cogent Biosciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

SSM Mastocytosis, Indolent Mastocytosis, Systemic Mastocytosis ISM BMM Smoldering Systemic Mastocytosis Bone Marrow Mastocytosis

Start date: 2022-06-27
Primary completion: 2025-05-22
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.